Ticker Scorecard - AVDL Basics Company: Avadel Pharmaceuticals plc IPO Date: July 1, 1996 Sector: Healthcare Industry: Pharma Market Cap: $985.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 3.11% Avg Daily Range (30 D): $0.23 | 2.19% Avg Daily Range (90 D): $0.27 | 2.18% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): 1.18M Avg Daily Volume (90 D): 1.06M Trade Size Avg Trade Size (Sh.): 146 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 896 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $1.42M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $1.29M Avg Closing Trade (90 D): $1.49M Avg Closing Volume: 157.34K     News Oct 18, 2024 @ 6:38 PM Avadel Obtains FDA Nod for Label Expansion Of Narc... Source: Zacks Aug 28, 2024 @ 12:00 PM Avadel Pharmaceuticals to Present at Upcoming Inve... Source: N/A Jun 27, 2024 @ 8:05 PM Avadel Pharmaceuticals to Join Russell 3000® In... Source: Avadel Pharmaceuticals plc Jun 21, 2024 @ 6:44 AM Harrow (HROW) Soars 12.9%: Is Further Upside Left ... Source: Zacks Equity Research May 22, 2024 @ 12:00 PM Avadel Pharmaceuticals Shares New LUMRYZâ„¢ (s... Source: Avadel Pharmaceuticals plc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.76 $-.03 $-.14 Diluted EPS $-.76 $-.03 $-.14 Revenue $ 138.16M $ 50.03M $ 41.5M Gross Profit $ 127M $ 43.87M $ 38.72M Net Income / Loss $ -72.58M $ -2.63M $ -13.82M Operating Income / Loss $ -64M $ -.33M $ -12.74M Cost of Revenue $ 11.16M $ 6.16M $ 2.79M Net Cash Flow $ -23.23M $ -.27M $ -6.95M PE Ratio